Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20348671 | 0.83 | — | — | |
| SCHEMBL17809660 | 0.76 | — | — | |
| SCHEMBL12574928 | 0.76 | TSHR (0.33) | — | |
| SCHEMBL13716521 | 0.75 | NFKB1 (0.33) | — | |
| SCHEMBL29686587 | 0.74 | PIK3CD (0.33) | — | |
| SCHEMBL12656700 | 0.73 | GABRR1 (0.34) | GABRR1 | |
| SCHEMBL29686766 | 0.72 | CCNE1 (0.33) | — | |
| SCHEMBL7563916 | 0.70 | GABRR1 (0.32) | GABRR1 | |
| SCHEMBL6277324 | 0.69 | CYP2C9 (0.37) | — | |
| SCHEMBL17733571 | 0.69 | AURKA (0.32) | GABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11371996-B2 | Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same | WATERS TECHNOLOGIES CORPORATION (US) | 2022-06-28 | — | — | US | disclosed |
| US-10436790-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2019-10-08 | — | — | US | disclosed |
| US-10416166-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-20180188259-A1 | METHODS FOR THE RAPID PREPARATION OF LABELED GLYCOSYLAMINES AND FOR THE ANALYSIS OF GLYCOSYLATED BIOMOLECULES PRODUCING THE SAME | WATERS TECHNOLOGIES CORPORATION (US) | 2018-07-05 | — | — | US | disclosed |
| US-9772333-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATER TECHNOLOGIES CORPORATION (US) | 2017-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10416166-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, CSGALNACT1 | GABRR1 3621/4885 |
| US-10436790-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, CSGALNACT1 | GABRR1 3079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.